keyword
https://read.qxmd.com/read/38652340/poorly-differentiated-mucinous-carcinoma-of-the-ascending-colon-complicated-by-bilateral-ovarian-mature-cystic-teratomas-in-a-17-year-old-female-patient-a-case-report
#1
JOURNAL ARTICLE
Takuya Shimogawa, Yukiharu Hiyoshi, Mayuko Ouchi, Keisuke Kosumi, Kojiro Eto, Satoshi Ida, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Nasa Okazaki, Yuko Miyasato, Hideo Baba
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide, and screening colonoscopy has led to a decreasing incidence rate. However, the incidence of CRC is increasing among young people, especially adolescents and young adults (AYAs) who are not routinely screened. Although CRC is the fourth most common cancer among AYAs, it is extremely rare. In younger patients, CRC is often diagnosed later, and the proportion of patients with advanced CRC is higher than that in older patients...
April 23, 2024: Surgical Case Reports
https://read.qxmd.com/read/38651158/diagnostic-value-of-one-step-nucleic-acid-amplification-for-sentinel-lymph-node-metastasis-in-cytokeratin-19-positive-tumors-evidence-from-bioinformatics-and-meta-analysis
#2
Ke Li, Min Meng, Weiwei Zhang, Junyi Li, Yiting Wang, Changhui Zhou
BACKGROUND: The status of the sentinel lymph nodes (SLNs) was an important prognostic factor in varies cancers. A one-step nucleic acid amplification (OSNA) assay, a molecular-based whole-node analysis method based on CK19 mRNA copy number, was developed to diagnose lymph node metastases. We aimed to evaluate the value of OSNA for the diagnosis of sentinel lymph node metastasis in CK19 positive cancers. CK19 mRNA and protein expression for pan-caner analysis were obtained from TCGA and the Human protein atlas database...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650941/editorial-harnessing-tumor-microenvironment-for-gynecologic-cancer-therapy
#3
EDITORIAL
Linying Zhou, Ming Yi
No abstract text is available yet for this article.
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650835/unveiling-the-nuances-of-adult-female-acne-a-comprehensive-exploration-of-epidemiology-treatment-modalities-dermocosmetics-and-the-menopausal-influence
#4
REVIEW
Marco Alexandre Dias da Rocha, Markéta Saint Aroman, Valérie Mengeaud, Fabienne Carballido, Gautier Doat, Ana Coutinho, Edileia Bagatin
Previously considered a skin disease exclusively affecting adolescents, characterized by inflammatory and non-inflammatory skin lesions, acne vulgaris is now increasingly observed in adult life, including post-menopause. Today, adult female acne (AFA) is a common chronic inflammatory disease of the pilosebaceous unit, with polymorphic lesions presenting as open or closed comedones, papules, pustules, and even nodules or cysts, often with the presence of sequelae. AFA may persist from adolescence or manifest de novo in adulthood...
2024: International Journal of Women's Health
https://read.qxmd.com/read/38650742/bioactive-compounds-from-morchella-esculenta-as-potential-inhibitors-of-rna-binding-protein-la-in-ovarian-cancer-a-molecular-modeling-and-quantum-mechanics-approach
#5
JOURNAL ARTICLE
Gbenga Dairo, Matthew N Ward, Mette Soendergaard, John J Determan
La protein is significantly expressed in various malignant tumors, including ovarian cancer (OC), which is related to the poor response to platinum-based chemotherapy. Thus, inhibiting La protein could control the expression of the potential downstream genes involved in promoting proliferation and chemotherapy resistance to OC, which could serve as a therapeutic intervention. Through a molecular docking approach, 12 compounds from Morchella esculenta were screened against the crystal structure of La protein and four hit compounds were identified, including beta-carotene, p -hydroxybenzoic acid, gamma-tocopherol, and alpha-tocopherol, with a binding affinity of - 10...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38650145/chelerythrine-induces-apoptosis-and-ferroptosis-through-nrf2-in-ovarian-cancer-cells
#6
JOURNAL ARTICLE
Jia Zhou, Yuchen Wang, Yangxin Fu, Zhe Lin, He Lin, Guangfu Lv, Ning Kong, Guo Xin, Fang Zhou, Zhidong Qiu, Xiaowei Huang
Ovarian cancer is a prevalent malignancy in the female reproductive system, representing a significantly fatal and incurable tumor. Chelerythrine (CHE), a natural benzopyridine alkaloid, has demonstrated a broad spectrum of anticancer activities. Nevertheless, the ovarian cancer inhibitory impact of CHE remains unclear. In this study, we investigated the cytotoxic mechanism and potential targets of CHE on in vitro cultures of A2780 and SKOV3 cells derived from ovarian cancer. Additionally, in vivo experiments were conducted to confirm the suppressive impact of CHE on tumor growth in nude mice...
March 31, 2024: Cellular and Molecular Biology
https://read.qxmd.com/read/38649975/astaxanthin-suppresses-the-malignant-behaviors-of-nasopharyngeal-carcinoma-cells-by-blocking-pi3k-akt-and-nf-%C3%AE%C2%BAb-pathways-via-mir-29a-3p
#7
JOURNAL ARTICLE
Yajia Xu, Chengyi Jiang
BACKGROUND: As a natural extraction, astaxanthin is gaining increasing attention because of its safety and anti-tumor properties. It has been reported to participate in the progression of various types of cancer such as gastric cancer and ovarian cancer. Nevertheless, the role of astaxanthin in nasopharyngeal carcinoma (NPC) has not been investigated. OBJECT: The study aimed to explore the anticancer mechanism of astaxanthin in regulating NPC cell proliferation, cell cycle progression, apoptosis, migration, and invasion...
April 22, 2024: Genes and Environment: the Official Journal of the Japanese Environmental Mutagen Society
https://read.qxmd.com/read/38648056/prevalence-of-homologous-recombination-deficiency-among-patients-with-germline-rad51c-d-breast-or-ovarian-cancer
#8
JOURNAL ARTICLE
Sara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, Marcel Romey, Àlex Teulé, Gemma Llort, Ana Herrero, Pilar Sánchez-Henarejos, Anna Vallmajó, Santiago González-Santiago, Isabel Chirivella, Juana Maria Cano, Begoña Graña, Sara Simonetti, Isabela Díaz de Corcuera, Teresa Ramon Y Cajal, Judit Sanz, Sara Serrano, Andrea Otero, Cristina Churruca, Ana Beatriz Sánchez-Heras, Sonia Servitja, Carmen Guillén-Ponce, Joan Brunet, Carsten Denkert, Violeta Serra, Judith Balmaña
IMPORTANCE: RAD51C and RAD51D are involved in DNA repair by homologous recombination. Germline pathogenic variants (PVs) in these genes are associated with an increased risk of ovarian and breast cancer. Understanding the homologous recombination deficiency (HRD) status of tumors from patients with germline PVs in RAD51C/D could guide therapeutic decision-making and improve survival. OBJECTIVE: To characterize the clinical and tumor characteristics of germline RAD51C/D PV carriers, including the evaluation of HRD status...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38646521/immunoglobulins-and-serum-proteins-impair-anti-tumor-nk-cell-effector-functions-in-malignant-ascites
#9
JOURNAL ARTICLE
Antonio Hrvat, Sonja Benders, Rainer Kimmig, Sven Brandau, Nina Mallmann-Gottschalk
INTRODUCTION: Malignant ascites indicates ovarian cancer progression and predicts poor clinical outcome. Various ascites components induce an immunosuppressive crosstalk between tumor and immune cells, which is poorly understood. In our previous study, imbalanced electrolytes, particularly high sodium content in malignant ascites, have been identified as a main immunosuppressive mechanism that impaired NK and T-cell activity. METHODS: In the present study, we explored the role of high concentrations of ascites proteins and immunoglobulins on antitumoral NK effector functions...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646501/progress-in-cancer-research-on-the-regulator-of-phagocytosis-cd47-which-determines-the-fate-of-tumor-cells-review
#10
REVIEW
Fan Wu, Hongyuan Pang, Fan Li, Mengqing Hua, Chuanwang Song, Jie Tang
Cluster of differentiation 47 (CD47) is a transmembrane protein that is widely and moderately expressed on the surface of various cells and can have an essential role in mediating cell proliferation, migration, phagocytosis, apoptosis, immune homeostasis and other related responses by binding to its ligands, integrins, thrombospondin-1 and signal regulatory protein α. The poor prognosis of cancer patients is closely associated with high expression of CD47 in glioblastoma, ovarian cancer, breast cancer, bladder cancer, colon cancer and hepatocellular carcinoma...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646138/granulosa-cell-tumor-of-the-ovary-a-series-of-6-cases
#11
Rafael Everton Assunção Ribeiro da Costa, Maria Clara Amorim Silva, Erlan Clayton Xavier Cavalcante, Rodrigo de Oliveira Castelo Branco, Cristiane Amaral Dos Reis, Sabas Carlos Vieira
Granulosa cell tumor (GCT) is a rare ovarian malignancy that represents only 2-3% of all cases. There are two subtypes of GCT: juvenile/JGCT (5% of cases) and adult/AGCT (95% of cases). This study aimed to describe a series of 6 GCT cases. The 6 study patients were managed from June 2011 to November 2022 in a private oncology clinic located in Teresina (PI), Brazil. At diagnosis, the mean patient age was 47 years, and symptoms in 5 patients (83%) were pelvic pain and/or increased abdominal volume. The majority of the patients (N=4/67%) had no comorbidities or findings related to GCT on physical examination...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38645982/yolk-sac-tumor-of-the-ovary-in-mosaic-46xx-turner-syndrome
#12
Alfonsus Zeus Suryawan, Dian Tjahyadi, Martin Hermawan, Doni Aprialdi
INTRODUCTION: Correlation of Turner syndrome (TS) with germ cell malignancy is acknowledge in TS patient with Y chromosome material but not otherwise. This case report wishes to highlight yolk sac tumor occurrence in patients with TS 46XX karyotype mosaicism. CASE REPORT: A 23-year-old nulligravid woman was admitted with abdominal mass and vaginal bleeding. She had primary amenorrhea and had already been diagnosed with TS. Her karyotype was 46XX with 5% X mosaicism...
2024: International Journal of Women's Health
https://read.qxmd.com/read/38645957/demons-meigs-syndrome-caused-by-a-giant-ovarian-fibroma-a-case-report
#13
Yousra Guelzim, Abdallah Bennasser, Salma Marrakchi, Abdelkader Sqalli Houssaini, Salwa Idoubba, Ismail Boujida, Ahmed Jahid, Nazik Allali, Latifa Chat, Siham El Haddad
Demons-Meigs syndrome is a very rare entity. It combines a benign ovarian "fibroma-like" tumor with ascites and hydrothorax. The notion of benignancy is the key point. CA-125 levels are most of the time normal, but high levels can be observed in rare cases which makes it difficult to have a diagnostic. We present here the case of a 43-year-old female patient who presented with abdominopelvic pain. Imaging discovered a 30 cm large intraabdominal mass with ascites and bilateral pleural effusion. Surgical resection of the tumor was performed, and pathology identified an ovarian fibroma...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38645548/interstitial-lung-disease-with-prolonged-fever-that-occurred-during-long-term-administration-of-olaparib-in-a-74-year-old-ovarian-cancer-patient-radiological-features-and-considerations-for-preventing-delayed-diagnosis
#14
Yoshinobu Saito, Rei Yamaguchi, Takahiro Suzuki, Junpei Sato, Nobuhiko Nishijima, Sho Saito, Junichi Aoyama, Namiko Taniuchi, Masahiro Seike, Noriyuki Katsumata
A 74-year-old woman, who had been receiving olaparib for the treatment of ovarian cancer for more than a year, visited the emergency department complaining of a fever that had lasted for 1 month. She had been taking antipyretics and antibiotics for her fever, but without any effect. Although she had no symptoms other than fever, she had stopped taking olaparib for 1 week before her visit because she had developed anemia caused by myelosuppression from olaparib. After discontinuing olaparib, her maximum body temperature decreased...
June 2024: Radiology Case Reports
https://read.qxmd.com/read/38645412/link-a-unveiling-its-functional-role-and-clinical-significance-in-human-tumors
#15
REVIEW
Bing Liao, Jialing Wang, Yilin Xie, Hongliang Luo, Jun Min
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer, ovarian cancer, glioma, non-small-cell lung cancer, and mantle cell lymphoma. Notably, LINK-A is involved in regulating critical cancer-related pathways, such as AKT and HIF1α signaling, and is implicated in a range of oncogenic activities, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), cell invasion and migration, and glycolysis reprogramming...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38645136/collateral-damage-of-nudt15-deficiency-in-cancer-provides-a-cancer-pharmacogenetic-therapeutic-window-with-thiopurines
#16
Jacob C Massey, Joseph Magagnoli, S Scott Sutton, Phillip J Buckhaults, Michael D Wyatt
Genome instability is a hallmark of cancer and are driven by mutations in oncogenes and tumor suppressor genes. Despite successes seen with select targeted therapeutics, this type of personalized medicine is only beneficial for a small subpopulation of cancer patients who have one of a few actionable genetic changes. Most tumors also contain hundreds of passenger mutations that offered no fitness advantage or disadvantage during tumor evolution. Mutations in known pharmacogenetic (PGx) loci for which germline variants encode variability in drug response can cause somatically acquired drug sensitivity...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38645083/folate-receptor-alpha-protein-expression-in-ovarian-serous-cystadenocarcinoma-tumors-of-the-cancer-genome-atlas-exploration-beyond-single-agent-therapy
#17
Christianne Persenaire, Benjamin G Bitler, Bradley R Corr
UNLABELLED: Epithelial ovarian cancer (EOC) can be highly lethal, with limited therapeutic options for patients with non-homologous recombination deficient (HRD) disease. Folate receptor alpha (FOLR1/FRα)-targeting agents have shown promise both alone and in combination with available therapies, but the relationship of FRα to other treatment-driving biomarkers is unknown. The Cancer Genome Atlas (TCGA) was queried to assess protein and mRNA expression and mutational burden in patients with differential FRα protein-expressing ovarian tumors, and the results referenced against the standard 324 mutations currently tested through FoundationOne Companion Diagnostics to identify targets of interest...
April 14, 2024: medRxiv
https://read.qxmd.com/read/38643468/an-lrpprc-hapstr1-psmd14-interaction-regulates-tumor-progression-in-ovarian-cancer
#18
JOURNAL ARTICLE
Dongxiao Li, Min Wang
Ovarian cancer is the second most common cause of gynecologic cancer death. Chemoresistance and metastasis remain major challenges for current treatment. Previously, HAPSTR1 was shown to be a target gene of a paclitaxel resistance-associated miRNA. However, the biological function and underlying molecular mechanisms of HAPSTR1 in ovarian cancer progression remain unclear. Herein, we aimed to measure HAPSTR1 expression in ovarian cancer specimens and examine its correlations with clinical features and key functional interactions with other genes and proteins...
April 18, 2024: Aging
https://read.qxmd.com/read/38642937/phase-1a-dose-escalation-study-of-ivonescimab-ak112-smt112-an-anti-pd-1-vegf-a-bispecific-antibody-in-patients-with-advanced-solid-tumors
#19
JOURNAL ARTICLE
Sophia Frentzas, Anna Rachelle Austria Mislang, Charlotte Lemech, Adnan Nagrial, Craig Underhill, Wenjing Wang, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Jermaine I G Coward
BACKGROUND: Studies showed that vascular endothelial growth factor (VEGF) inhibitors could improve therapeutic efficacy of PD-1/PD-L1 antibodies by transforming the immunosuppressive tumor microenvironment (TME) into an immunoresponsive TME. Ivonescimab is a first-in-class, humanized tetravalent bispecific antibody targeting PD-1 and VEGF-A simultaneously. Here, we report the first-in-human, phase 1a study of ivonescimab in patients with advanced solid tumors. METHODS: Patients with advanced solid tumors were treated with ivonescimab 0...
April 19, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38642607/deciphering-a-gpcr-lncrna-mirna-nexus-identification-of-an-aberrant-therapeutic-target-in-ovarian-cancer
#20
JOURNAL ARTICLE
Ji Hee Ha, Rangasudhagar Radhakrishnan, Revathy Nadhan, Rohini Gomathinayagam, Muralidharan Jayaraman, Mingda Yan, Srishti Kashyap, Kar-Ming Fung, Chao Xu, Resham Bhattacharya, Priyabrata Mukherjee, Ciro Isidoro, Yong Sang Song, Danny N Dhanasekaran
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies, primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear understanding of disease etiology. Previous studies have identified the pivotal role of Lysophosphatidic acid (LPA)-signaling in ovarian cancer pathobiology. Our earlier transcriptomic analysis identified Urothelial Carcinoma Associated-1 (UCA1) as an LPA-stimulated long non-coding RNA (lncRNA). In this study, we elucidate the tripartite interaction between LPA-signaling, UCA1, and let-7 miRNAs in ovarian cancer progression...
April 18, 2024: Cancer Letters
keyword
keyword
46046
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.